(Q33916931)

30 July 2017

1 reference

title

Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector (English)

1 reference

30 July 2017

1 reference

30 July 2017

Picano E

1 reference

30 July 2017

publication date

1 May 2000

1 reference

30 July 2017

published in

Brain Research Bulletin

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

75-82

1 reference

Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine A3 receptors and viability of astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

The cardiac effects of adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

1 reference

7 January 2021

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Protective effects of adenosine in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine stimulation of DNA synthesis in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Intravenous adenosine and lidocaine in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine-induced cell death: evidence for receptor-mediated signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

'Ischemic tolerance' phenomenon found in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Increase in plasma adenosine during brain ischemia in man: a study during transient ischemic attacks, and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Preconditioning of human myocardium with adenosine during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Activation of sympathetic tone during dipyridamole test

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Enhanced prostacyclin production by dipyridamole in man

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Cardiovascular purinoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Platelet-active drugs: the relationships among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Dipyridamole-echocardiography test: historical background and physiologic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Stress echocardiography. From pathophysiological toy to diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Dipyridamole in the treatment of angina pectoris: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Protective Mechanisms of Adenosine in Neurons and Glial Cellsa

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine A3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by alpha2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Salvage of jeopardized myocardium by ischemic preconditioning: is the quest over?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role for adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine A3 receptor stimulation and cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900249-5

7 January 2021

10.1016/S0361-9230(00)00249-5

Identifiers

DOI

1 reference

30 July 2017

1 reference